Aoxing Pharmaceutical Company, Inc. Announces Earnings Results for the Third Quarter and Nine Month Periods Ended March 31, 2013
May 15, 2013 at 09:22 pm
Share
Aoxing Pharmaceutical Company, Inc. announced earnings results for the third quarter and nine month periods ended March 31, 2013. For the quarter, the company reported revenues of $1,885,133, representing a 4% increase over the revenues realized in the comparable periods of fiscal year 2012. The increase in revenue was mainly attributable to the increase in sales of its main product, Zhongtongan, which is now being marketed for gynecological and orthopaedic applications in addition to its core pediatric and stomotological market. Losses from operations were $2,300,366 compared with losses from operations of $436,953 during the same periods a year earlier. Net losses were $2,729,350.
For the nine months, the company reported revenues of $7,804,664, representing a 43% increase over the revenues realized in the comparable periods of fiscal year 2012. The increase in revenue was mainly attributable to the increase in sales of its main product, Zhongtongan, which is now being marketed for gynecological and orthopaedic applications in addition to its core pediatric and stomotological market. Losses from operations were $4,565,272 compared with losses from operations of $1,083,770 during the same periods a year earlier. Net losses were $6,313,526.
Aoxing Pharmaceutical Company, Inc. is a specialty pharmaceutical company specializing in research, development, manufacturing and distribution of a range of narcotic, pain-management and addiction treatment pharmaceutical products. The Company holds approximately 140 drug production certificates covering narcotic pain-management, prescription medicines, over-the-counter (OTC) and active pharmaceutical ingredient (API) products. Its products include prescription drugs, such as Tilidine hydrochloride, Zhongtong'an and Humifuse Euphorbia Herb Tablet, and OTC drugs, such as Shanmei Capsule, Shaoshang Tincture, Yiqi Qiangshen Granule, Xiaopiling Granule, Xiongjushangqing Tablet, Juyuansuanbijia Oral Solutions, Longdanxiegan Tablet, Fenka Tablet, Shujinhuoxue Tablet, Fuketiaojing Tablet, Qingnao Jiangya Tablet, Yuanhu Pain Management Tablet, Bushenqiangshen Tablet, Baiziyangxin Pill, Qingguo Pill, Liuweidihuang Pill, Zhibaidihuang Pill, Xiaoyao Pill and Tianwangbuxin Pill.